Hospital
Mayo Clinic Health System-Fairmont
Mayo Clinic Health System-Fairmont was paid $9.04M by Medicaid between Jan 2018 and Dec 2024, across 83 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 44% of everything it billed.
33Billing provider infoMAYO CLINIC HEALTH SYSTEM-FAIRMONT
FAIRMONT, MN 56031
FAIRMONT, MN 56031
33aNPI1821066499assigned 03/09/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.04M
24GClaims130,540
24DCodes billed83
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Minnesota
Rank by total paid#20 of 36
Median peer was paid$11.46M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MEKALA, PRAVEEN controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,688 | $552K | |
| 2019 | 20,277 | $1.36M | |
| 2020 | 16,478 | $1.04M | |
| 2021 | 24,231 | $1.45M | |
| 2022 | 23,399 | $1.75M | |
| 2023 | 18,442 | $1.61M | |
| 2024incomplete | 10,025 | $1.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 44% | 58,256 | 51,653 | $4.02M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 9,545 | 8,990 | $1.82M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 2,769 | 2,416 | $1.02M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 4,431 | 3,911 | $1.00M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2.0% | 2,093 | 2,063 | $182K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 1.5% | 1,810 | 1,335 | $135K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.3% | 5,878 | 5,668 | $120K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,011 | 994 | $89K |
| 36415 | Collection of venous blood by venipuncture | <1% | 16,936 | 15,273 | $79K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 563 | 540 | $67K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 369 | 345 | $57K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 762 | 743 | $55K |
71 more codes
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 389 | $53K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 937 | $48K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 555 | $41K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,786 | $28K |
| 87631 | <1% | 1,186 | $24K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 111 | $20K |
| 96127 | <1% | 650 | $19K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 669 | $17K |
| 80053 | Comprehensive metabolic panel | <1% | 3,103 | $15K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 686 | $15K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,075 | $12K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,594 | $8K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 117 | $8K |
| 90837 | Psychotherapy session, about an hour | <1% | 49 | $7K |
| 0002A | <1% | 495 | $6K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 111 | $6K |
| 0001A | <1% | 492 | $6K | |
| 90686 | <1% | 868 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 717 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 217 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 89 | $4K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 74 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 162 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 162 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 44 | $3K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 69 | $3K |
| 98927 | <1% | 130 | $2K | |
| 73630 | <1% | 35 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 111 | $2K |
| 80061 | Lipid panel | <1% | 161 | $2K |
| 85610 | <1% | 1,179 | $2K | |
| 87070 | <1% | 91 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 240 | $1K |
| Q3014 | Telehealth originating site facility fee | <1% | 48 | $1K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 15 | $1K |
| 81001 | <1% | 240 | $1K | |
| 90461 | <1% | 138 | $1K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 14 | $1K |
| 0004A | <1% | 67 | $1K | |
| 92552 | <1% | 12 | $817.24 | |
| 83690 | <1% | 39 | $809.85 | |
| 11721 | <1% | 44 | $544.22 | |
| 86850 | <1% | 39 | $347.60 | |
| 84484 | <1% | 14 | $333.84 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 90 | $291.51 |
| 83880 | <1% | 12 | $279.38 | |
| 90670 | <1% | 39 | $245.98 | |
| 92015 | Determination of refractive state | <1% | 85 | $119.18 |
| 97803 | <1% | 13 | $105.43 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13 | $104.32 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 13 | $86.90 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 98 | $78.50 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 136 | $76.80 |
| G0008 | Administration of influenza virus vaccine | <1% | 12 | $63.22 |
| 82248 | <1% | 79 | $55.52 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 233 | $38.93 |
| 83735 | <1% | 14 | $36.39 | |
| 86140 | <1% | 13 | $11.62 | |
| 83605 | 0% | 38 | $0.00 | |
| 85027 | 0% | 42 | $0.00 | |
| 91307 | 0% | 15 | $0.00 | |
| 85379 | 0% | 14 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 31 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 190 | $0.00 |
| 81025 | 0% | 13 | $0.00 | |
| 91300 | 0% | 787 | $0.00 | |
| 90685 | 0% | 21 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 27 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 15 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 30 | $0.00 |
| 87634 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMEKALA, PRAVEEN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Mayo Clinic Health System-Southeast Minnesota Region | Albert Lea, MN | $37.49M |
| Mayo Clinic Health System-Southwest Minnesota Region | Mankato, MN | $28.51M |
| Mayo Clinic Health System-Southeast Minnesota Region | Albert Lea, MN | $21.76M |
| Mayo Clinic Health System-Southeast Minnesota Region | Owatonna, MN | $13.72M |
| Mayo Clinic Health System-Southeast Minnesota Region | Albert Lea, MN | $12.58M |
| Mayo Clinic Health System-Southeast Minnesota Region | Red Wing, MN | $6.56M |
| Mayo Clinic Health System-Fairmont | Fairmont, MN | $4.71M |
| Mayo Clinic Health System-Southeast Minnesota Region | Red Wing, MN | $4.42M |
| Mayo Clinic Health System-Southwest Minnesota Region | Waseca, MN | $2.72M |
| Mayo Clinic Health System-Southwest Minnesota Region | New Prague, MN | $1.41M |
| Mayo Clinic Health System-Lake City | Lake City, MN | $653K |
| Mayo Clinic Health System-Southeast Minnesota Region | Cannon Falls, MN | $520K |
| Mayo Clinic Health System-Lake City | Lake City, MN | $265K |
| Mayo Clinic Health System-Lake City | Lake City, MN | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.